drugset / Trial / NCT06422221

An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures

NCT06422221

RandomizedParallel-groupSingle-blindPrevention

Summary

Although controversy exists regarding the efficacy of antibiotic prophylaxis for patients at risk of infective endocarditis, expert committees continue to publish recommendations for antibiotic prophylactic regimens. The last American Heart Association (AHA) and European Society of Cardiology (ESC) guidelines include several important changes, highlighting that clindamycin (CLI) is no longer recommended as an alternative to amoxicillin in those allergic to penicillin. This new project aims to evaluate the effectiveness of oral doxycycline in preventing post-dental extraction bloodstream infection.

Timeline

Start
2024-07-15
Primary completion
2025-01-15
Completion
2025-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clindamycin Unknown 600 mg Oral
Comparator Doxycycline Small molecule 100 mg Oral